StockData
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA) stock

SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3078% below fair value
$1.09−0.08 (-6.84%)

Close on Nov 13, 2026Market cap $5.22MP/E –Yield –

Sonoma Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Sonoma Pharmaceuticals's ebitda for the twelve months ending Jun 30, 2026 was -$1.27M. For fiscal 2026 it was -$2.32M. The highest annual figure on record is -$2.32M in fiscal 2026.

Annual ebitda

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$2.32M–
FY2025Mar 31, 2025-$3.57M–
FY2024Mar 31, 2024-$4.53M–
FY2023Mar 31, 2023-$4.45M–
FY2022Mar 31, 2022-$5.70M–
FY2021Mar 31, 2021-$3.22M–
FY2020Mar 31, 2020-$7.08M–
FY2019Mar 31, 2019-$10.81M–
FY2018Mar 31, 2018-$13.70M–
FY2017Mar 31, 2017-$12.73M–
FY2016Mar 31, 2016-$14.47M–
FY2015Mar 31, 2015-$6.41M–
FY2014Mar 31, 2014-$5.77M–
FY2013Mar 31, 2013-$3.11M–
FY2012Mar 31, 2012-$6.14M–
FY2011Mar 31, 2011-$7.11M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$8.00K–
Q4 FY2026CQ1 2026Mar 31, 2026-$318.00K–
Q3 FY2026CQ4 2025Dec 31, 2025-$644.00K–
Q2 FY2026CQ3 2025Sep 30, 2025-$301.00K–
Q1 FY2026CQ2 2025Jun 30, 2025-$1.06M–
Q4 FY2025CQ1 2025Mar 31, 2025-$625.00K–
Q3 FY2025CQ4 2024Dec 31, 2024-$998.00K–
Q2 FY2025CQ3 2024Sep 30, 2024-$815.00K–
Q1 FY2025CQ2 2024Jun 30, 2024-$1.13M–
Q4 FY2024CQ1 2024Mar 31, 2024-$1.37M–
Q3 FY2024CQ4 2023Dec 31, 2023-$799.00K–
Q2 FY2024CQ3 2023Sep 30, 2023-$1.16M–
Q1 FY2024CQ2 2023Jun 30, 2023-$1.20M–
Q4 FY2023CQ1 2023Mar 31, 2023-$1.11M–
Q3 FY2023CQ4 2022Dec 31, 2022-$1.80M–
Q2 FY2023CQ3 2022Sep 30, 2022-$703.00K–
Q1 FY2023CQ2 2022Jun 30, 2022-$824.00K–
Q4 FY2022CQ1 2022Mar 31, 2022-$3.01M–
Q3 FY2022CQ4 2021Dec 31, 2021-$921.00K–
Q2 FY2022CQ3 2021Sep 30, 2021-$912.00K-509.0%
Q1 FY2022CQ2 2021Jun 30, 2021-$856.00K–
Q4 FY2021CQ1 2021Mar 31, 2021-$2.77M–
Q3 FY2021CQ4 2020Dec 31, 2020-$58.00K–
Q2 FY2021CQ3 2020Sep 30, 2020$223.00K–
Q1 FY2021CQ2 2020Jun 30, 2020-$612.00K–
Q4 FY2020CQ1 2020Mar 31, 2020-$3.12M–
Q3 FY2020CQ4 2019Dec 31, 2019-$1.04M–
Q2 FY2020CQ3 2019Sep 30, 2019-$1.22M–
Q1 FY2020CQ2 2019Jun 30, 2019-$1.70M–
Q4 FY2019CQ1 2019Mar 31, 2019-$2.60M–
Q3 FY2019CQ4 2018Dec 31, 2018-$2.24M–
Q2 FY2019CQ3 2018Sep 30, 2018-$2.54M–
Q1 FY2019CQ2 2018Jun 30, 2018-$3.43M–
Q4 FY2018CQ1 2018Mar 31, 2018-$4.63M–
Q3 FY2018CQ4 2017Dec 31, 2017-$3.08M–
Q2 FY2018CQ3 2017Sep 30, 2017-$2.73M–
Q1 FY2018CQ2 2017Jun 30, 2017-$3.27M–
Q4 FY2017CQ1 2017Mar 31, 2017-$2.84M–
Q3 FY2017CQ4 2016Dec 31, 2016-$3.51M–

More Sonoma Pharmaceuticals figures

See a number that looks wrong?